Want to join the conversation?
$PFE said that as per its agreement with RPI, a subsidiary of Royalty Pharma, RPI will fund up to $300MM in development costs related to certain Phase III clinical trials of $PFE's breast cancer drug Ibrance. For up to 3 years post Hospira acquisition, $PFE expects costs to be $1Bil, excluding costs of $215MM in 2015 for in-process R&D rights.
$SBUX launched its annual “Starbucks for Life” competition in the U.S. and Canada. The winner of the competition will receive a credit of one drink or food item per day for a duration of 30 years.
$T shares rose 1.8%, as a big boost for the S&P 500. The company said its new streaming television service DirectTV has so far exceeded expectations.
$TXMD flying high.. anyone here to catch..?
$CMG crashing. There seems to be nothing good to read about this company.